Events & Presentations


Events & Presentations

Upcoming Events
More events are coming soon.
Archived Events
Date Event Details
Oct 4, 2018 8:30 AM EDT
Arrowhead/Janssen Collaboration Call
Oct 2, 2018 10:55 AM EDT
2018 Cantor Fitzgerald Global Healthcare Conference
New York, NY
Christopher Anzalone, Ph.D., Arrowhead’s president and chief executive officer, will deliver a corporate presentation
Sep 30 - Oct 3, 2018
The 14th Annual Meeting of the Oligonucleotide Therapeutics Society
Seattle, WA

October 1, 9:20 a.m. PDT – Zhen Li, Ph.D., Arrowhead’s senior vice president of chemistry and non-clinical development, will deliver an oral presentation titled, “Direct conjugation approaches in RNAi come of age – Successful delivery outside of hepatocytes”

October 1, 5:00 p.m. PDT – Rui Zhu, Ph.D., Arrowhead’s senior process chemist, will deliver a poster presentation titled, “Subcutaneous delivery of an effective RNA interference (RNAi) therapeutic candidate silencing angiopoietin-like protein 3 for treatment of hyperlipidemia”

October 3,4:00 p.m. PDT – James Hamilton M.D., MBA,Arrowhead’s vice president of clinical development, will deliver an invited, late-breaker oral presentation titled, “Clinical Development of RNAi Therapeutics for HBV and Alpha-1 Antitrypsin Deficiency”

Sep 25, 2018 12:00 PM EDT
Antivirals: Targeting HBV and Beyond
James Hamilton, M.D., Arrowhead’s vice president of clinical development, will deliver an oral presentation titled, “Using siRNA to target the HBV transcriptome”
Sep 16, 2018 12:15 PM CDT
European Respiratory Society International Congress 2018
September 16, 12:15 p.m. CEST – Erik Bush, Ph.D., Arrowhead’s director of extra-hepatic targeting, will deliver an oral presentation titled, Targeting ENaC with an epithelial RNAi trigger delivery platform for the treatment of cystic fibrosis”
Sep 7, 2018 5:45 PM EDT
18th World Gastroenterologists Summit
September 7, 09:45 a.m. NZST – Dr. Given will deliver a keynote presentation titled, “Hepatitis B in focus: New biology, new targets and real hope for finite therapy”
Sep 4, 2018
Annual B. Riley FBR Healthcare Conference
Bruce Given, M.D., Arrowhead’s chief operating officer, and Vincent Anzalone, CFA, vice president of investor relations, will participate in three panel discussions
Aug 7, 2018 4:30 PM EDT
Arrowhead Fiscal 2018 Third Quarter Results
Jun 29, 2018 3:45 PM PDT
27th Annual Alpha-1 National Education Conference
San Francisco, CA
Bruce Given, M.D., will deliver an oral presentation titled, “Development of ARO-AAT, an RNAi based therapeutic for Alpha-1 antitrypsin deficiency-related liver disease”
Jun 20, 2018 9:00 AM EDT
JMP Securities Life Science Conference
New York, NY
Bruce Given, M.D., will present a corporate overview